{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:08:51Z","timestamp":1785272931626,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1245\/s10434-016-5545-0","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T16:37:19Z","timestamp":1473698239000},"page":"634-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increasing Appropriate BRCA1\/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic"],"prefix":"10.1245","volume":"23","author":[{"given":"Amar U.","family":"Kishan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin L.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nova M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Hurvitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kusske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"5545_CR1","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","volume":"359","author":"WD Foulkes","year":"2008","unstructured":"Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008;359:2143\u201353.","journal-title":"N Engl J Med."},{"key":"5545_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2014.05.028","volume":"134","author":"E Lokich","year":"2014","unstructured":"Lokich E, Stuckey A, Raker C, Wilbur JS, Laprise J, Gass J. Preoperative genetic testing affects surgical decision making in breast cancer patients. Gynecol Oncol. 2014;134:326\u201333.","journal-title":"Gynecol Oncol."},{"key":"5545_CR3","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/cncr.23903","volume":"113","author":"GF Schwartz","year":"2008","unstructured":"Schwartz GF, Hughes KS, Lynch HT, et al. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April 2007. Cancer. 2008;113:2627\u201337.","journal-title":"Cancer."},{"key":"5545_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"PD Pharoah","year":"2002","unstructured":"Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31:33\u20136.","journal-title":"Nature Genet."},{"key":"5545_CR5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:271\u201381.","journal-title":"Ann Intern Med."},{"key":"5545_CR6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676\u201389.","journal-title":"Am J Hum Genet."},{"key":"5545_CR7","unstructured":"NCCN. NCCN clinical practice guidelines in oncology: genetic\/familial high-risk assessment: breast and ovarian, v2.2016. NCCN."},{"key":"5545_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jamaoncol.2015.5941","volume":"2","author":"SM Rosenberg","year":"2016","unstructured":"Rosenberg SM, Ruddy KJ, Tamimi RM, et al. BRCA1 and BRCA2 mutation testing in young women with breast cancer. JAMA Oncol. 2016;2:730\u20136.","journal-title":"JAMA Oncol."},{"key":"5545_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-015-3658-y","volume":"155","author":"KL Kehl","year":"2016","unstructured":"Kehl KL, Shen C, Litton JK, Arun B, Giordano SH. Rates of BRCA1\/2 mutation testing among young survivors of breast cancer. Breast Cancer Res Treat. 2016;155:165\u201373.","journal-title":"Breast Cancer Res Treat."},{"key":"5545_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2012\/298745","volume":"2012","author":"B Anderson","year":"2012","unstructured":"Anderson B, McLosky J, Wasilevich E, Lyon-Callo S, Duquette D, Copeland G. Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol. 2012;2012:11.","journal-title":"J Cancer Epidemiol."},{"key":"5545_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-015-3374-7","volume":"151","author":"D Cragun","year":"2015","unstructured":"Cragun D, Bonner D, Kim J, et al. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat. 2015;151:169\u201376.","journal-title":"Breast Cancer Res Treat."},{"key":"5545_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2015.04.029","volume":"138","author":"T Febbraro","year":"2015","unstructured":"Febbraro T, Robison K, Wilbur JS, et al. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. Gynecol Oncol. 2015;138:109\u201314.","journal-title":"Gynecol Oncol."},{"key":"5545_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","volume":"13","author":"DE Levy","year":"2011","unstructured":"Levy DE, Byfield SD, Comstock CB, et al. Underutilization of BRCA1\/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk. Genet Med. 2011;13:349\u201355.","journal-title":"Genet Med."},{"key":"5545_CR14","first-page":"3596","volume":"119","author":"AM McCarthy","year":"2013","unstructured":"McCarthy AM, Bristol M, Fredricks T, et al. Are physician recommendations for BRCA1\/2 testing in patients with breast cancer appropriate? A population-based study. Cancer. 2013;119:3596\u2013603.","journal-title":"A population-based study. Cancer."},{"key":"5545_CR15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0b013e318280f2b4","volume":"23","author":"CB Powell","year":"2013","unstructured":"Powell CB, Littell R, Hoodfar E, Sinclair F, Pressman A. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling? Int J Gynecol Cancer. 2013;23:431\u20136.","journal-title":"Int J Gynecol Cancer."},{"key":"5545_CR16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2013.51.4661","volume":"32","author":"ME Wood","year":"2014","unstructured":"Wood ME, Kadlubek P, Pham TH, et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol. 2014;32:824\u20139.","journal-title":"J Clin Oncol."},{"key":"5545_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/COC.0000000000000073","volume":"39","author":"A Stuckey","year":"2014","unstructured":"Stuckey A, Febbraro T, Laprise J, Wilbur JS, Lopes V, Robison K. Adherence patterns to National Comprehensive Cancer Network guidelines for referral of women with breast cancer to genetics professionals. Am J Clin Oncol. 2014;39:363\u20137.","journal-title":"Am J Clin Oncol."},{"key":"5545_CR18","first-page":"239","volume":"27","author":"HJ Murff","year":"2004","unstructured":"Murff HJ, Byrne D, Syngal S. Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med. 2004;27:239\u201345.","journal-title":"Am J Prev Med."},{"key":"5545_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2296-11-45","volume":"11","author":"BS Flynn","year":"2010","unstructured":"Flynn BS, Wood ME, Ashikaga T, Stockdale A, Dana GS, Naud S. Primary care physicians\u2019 use of family history for cancer risk assessment. BMC Fam Pract. 2010;11:45.","journal-title":"BMC Fam Pract."},{"key":"5545_CR20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1542-3565(04)00352-0","volume":"2","author":"S Grover","year":"2004","unstructured":"Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol. 2004;2:813\u20139.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"5545_CR21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/00001888-200008000-00021","volume":"75","author":"RT Acton","year":"2000","unstructured":"Acton RT, Burst NM, Casebeer L, et al. Knowledge, attitudes, and behaviors of Alabama\u2019s primary care physicians regarding cancer genetics. Acad Med. 2000;75:850\u20132.","journal-title":"Acad Med."},{"key":"5545_CR22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/152460900750020900","volume":"9","author":"L Wilkins-Haug","year":"2000","unstructured":"Wilkins-Haug L, Erickson K, Hill L, Power M, Holzman GB, Schulkin J. Obstetrician-gynecologists\u2019 opinions and attitudes on the role of genetics in women\u2019s health. J Women Health Gend Based Med. 2000;9:873\u20139.","journal-title":"J Women Health Gend Based Med."},{"key":"5545_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2014.07.016","volume":"113","author":"G Decker","year":"2014","unstructured":"Decker G, Murtz P, Gieseke J, et al. Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol. 2014;113:115\u201320.","journal-title":"Radiother Oncol."},{"key":"5545_CR24","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.2014.56.8378","volume":"32","author":"JL Haidle","year":"2014","unstructured":"Haidle JL . Important differences between a triage pedigree and risk assessment. J Clin Oncol. 2014;32:3345\u20136.","journal-title":"J Clin Oncol."},{"key":"5545_CR25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117\u201330.","journal-title":"Am J Hum Genet."},{"key":"5545_CR26","unstructured":"NCCN. NCCN clinical practice guidelines in oncology: breast cancer, v2.2016. NCCN."},{"key":"5545_CR27","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","volume":"22","author":"MD Schwartz","year":"2004","unstructured":"Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004;22:1823\u20139.","journal-title":"J Clin Oncol."},{"key":"5545_CR28","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archsurg.138.12.1323","volume":"138","author":"JN Weitzel","year":"2003","unstructured":"Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg. 2003;138:1323\u20138, (discussion 1329).","journal-title":"Arch Surg."},{"key":"5545_CR29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","volume":"132","author":"C Garcia","year":"2014","unstructured":"Garcia C, Wendt J, Lyon L, et al. Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol. 2014;132:428\u201333.","journal-title":"Gynecol Oncol."},{"key":"5545_CR30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12916-015-0425-1","volume":"13","author":"L Livraghi","year":"2015","unstructured":"Livraghi L, Garber JE. PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med. 2015;13:188.","journal-title":"BMC Med."},{"key":"5545_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1525-1497.2004.30401.x","volume":"19","author":"EC Rich","year":"2004","unstructured":"Rich EC, Burke W, Heaton CJ, et al. Reconsidering the family history in primary care. J Gen Intern Med. 2004;19:273\u201380.","journal-title":"J Gen Intern Med."},{"key":"5545_CR32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jama.2014.12483","volume":"312","author":"MC King","year":"2014","unstructured":"King MC, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA. 2014;312:1091\u20132.","journal-title":"JAMA."},{"key":"5545_CR33","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamaoncol.2015.2340","volume":"1","author":"EF Long","year":"2015","unstructured":"Long EF, Ganz PA. Cost-effectiveness of universal BRCA1\/2 screening: evidence-based decision making. JAMA Oncol. 2015;1:1217\u20138.","journal-title":"JAMA Oncol."},{"key":"5545_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ypmed.2004.09.041","volume":"41","author":"CP Kaplan","year":"2005","unstructured":"Kaplan CP, Haas JS, Perez-Stable EJ, Des Jarlais G, Gregorich SE. Factors affecting breast cancer risk reduction practices among California physicians. Prev Med. 2005;41:7\u201315.","journal-title":"Prev Med."},{"key":"5545_CR35","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1002\/cncr.26166","volume":"117","author":"KF Trivers","year":"2011","unstructured":"Trivers KF, Baldwin LM, Miller JW, et al. Reported referral for genetic counseling or BRCA1\/2 testing among United States physicians: a vignette-based study. Cancer. 2011;117:5334\u201343.","journal-title":"Cancer."},{"key":"5545_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2354.2008.01065.x","volume":"19","author":"E Riel Van","year":"2010","unstructured":"Van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG. BRCA testing of breast cancer patients: medical specialists\u2019 referral patterns, knowledge, and attitudes to genetic testing. Eur J Cancer Care Engl. 2010;19:369\u201376.","journal-title":"Eur J Cancer Care Engl."},{"key":"5545_CR37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-007-9680-y","volume":"109","author":"KJ Schlich-Bakker","year":"2008","unstructured":"Schlich-Bakker KJ, Ausems MG, Schipper M, Ten Kroode HF, Warlam-Rodenhuis CC, van den Bout J. BRCA1\/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy. Breast Cancer Res Treat. 2008;109:507\u201314.","journal-title":"Breast Cancer Res Treat."},{"key":"5545_CR38","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.ejca.2006.05.032","volume":"42","author":"KJ Schlich-Bakker","year":"2006","unstructured":"Schlich-Bakker KJ, Warlam-Rodenhuis CC, van Echtelt J, van den Bout J, Ausems MG, ten Kroode HF. Short-term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer. Eur J Cancer. 2006;42:2722\u20138.","journal-title":"Eur J Cancer."},{"key":"5545_CR39","unstructured":"Ralph J, Coates P. Counseling US women on BRCA testing, a new healthy people 2020 objective: findings from the national health interview survey, 2000\u20132005. Lansing, MI: Michigan. Department of Community Health Promoting Cancer Genomics Best Practives Steering Committee. 2010."},{"key":"5545_CR40","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1245\/s10434-012-2460-x","volume":"19","author":"J Christie","year":"2012","unstructured":"Christie J, Quinn GP, Malo T, et al. Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients. Ann Surg Oncol. 2012;19:4003\u201311.","journal-title":"Ann Surg Oncol."},{"key":"5545_CR41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M, et al. Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol. 2015;1:943\u201351.","journal-title":"JAMA Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5545-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:16:28Z","timestamp":1749579388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5545-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":41,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["5545"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5545-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}